< = > less is more. De-diagnosing De-prescribing Non-testing

Size: px
Start display at page:

Download "< = > less is more. De-diagnosing De-prescribing Non-testing"

Transcription

1 < = > less is more De-diagnosing De-prescribing Non-testing

2 Who says? Overdiagnosis Polypharmacy False positives Too much medicine Risk aversion $$$

3 Sources Prof David Le Couteur, Clin Pharm and Aged Care Preventing Overdiagnosis Conference 2016

4 Sources Evidence-Based Medicine 2012

5 Language IMU = inappropriate medication use IMUP = inappropriate med use w polypharmacy PIM = potentially inappropriate medication POM = prescribing optimisation method ADR = adverse drug reactions DDIs = drug-drug interactions DBI = drug burden index VOCODFLEX = very old age, the extent of comorbidity, dementia, frailty and limited life expectancy CRIME = Criteria to Assess Appropriate Medication Use Among Elderly Complex Patients

6 Concept of De-Diagnosis Age-appropriate BP vs hypertension Diabetic control in the elderly Bacteruria vs UTI Ankle oedema High cholesterol Don t have it -> no need to treat it.

7

8 Need to understand: The individual, robust vs frail, their therapeutic goals The benefits and risks of all of their medicines + combination Ethics of autonomy, dignity of risk, preferences Very limited evidence on the safety and efficacy of medicines in older adults, particularly in the frail, who often have multiple comorbidities and functional impairments. In robust older patients, therapy usually aims to delay or cure disease and to minimise functional impairment. In frail older patients, symptom control, maintaining function and addressing end-of-life issues become the main priorities.

9

10 Patient-based issues Fear of change My doctor said I should stay on it for life Worry about what might happen: They said I could get a stroke or heart attack All my friends are on it for life Generational: perceived benefit of medications Perception of age discrimination -> need explanation and reassurance cooperation with primary care provider (Help patient negotiate with PCP)

11 Which meds? Statins, gastric acid suppressive agents, angiotensin-converting enzyme inhibitors/angiotensin receptor antagonists and inhaled bronchodilators were the most frequently ceased medications ANTICHOLINERGICS

12 Prescription cascade pain due to osteoarthrosis NSAID prescribed NSAID induces hypertension more antihypertensive drugs drug-induced nausea metoclopramide extrapyramidal symptoms wrong diagnosis of Parkinson s disease levodopa orthostatic hypotension (falls) and delirium antipsychotics; dihydropyridine-induced leg edema furosemide and potassium automatically prescribing H2 blockers to patients on NSAID delirium in older people erroneous treatment with neuroleptics cold medications containing compounds with anticholinergic properties urinary retention α blocker falls (Source: Ther Adv Drug Safety 2015 Routine deprescribing of chronic medications to combat polypharmacy)

13 Tools STOPP/START criteria Beers criteria Medication Appropriateness Index Improved prescribing in the Elderly Tool (IPET)

14

15

16 Beers criteria List of over 50 drugs or drug classes to be avoided in older ppl, incl:

17 Medication Appropriateness Index

18 BUT...risks Withdrawal reaction Return of previously controlled diseases

19 Non-testing Not yet well-developed literature Take a good history, work out likely pathophysiology, explain to patient Discuss balance of risks not confirming diagnosis vs false +ve/discomfort/cost Agree on a plan for f/up /review ( If you still have it next week...)

20 Latest issue EMA Review: Probiotics to prevent antibiotic-associated diarrhoea in kids: Antibiotics are commonly prescribed for children, sometimes even when clinically indicated From a societal perspective, more benefit could probably be achieved by only prescribing antibiotics to children who truly need them

21

Appropriate prescribing and deprescribing for older people getting it right. Alan Davis Northland District Health Board

Appropriate prescribing and deprescribing for older people getting it right. Alan Davis Northland District Health Board Appropriate prescribing and deprescribing for older people getting it right Alan Davis Northland District Health Board Unused returns Potentially inappropriate medication use in the elderly 15% of older

More information

Deconstructing Polypharmacy. Alan B. Douglass, M.D. Director

Deconstructing Polypharmacy. Alan B. Douglass, M.D. Director Deconstructing Polypharmacy Alan B. Douglass, M.D. Director Recognize this patient? Mrs. Brown- 82 years young Active Medical Problems Hypertension Hyperlipidemia Type 2 Diabetes Peripheral edema Osteoarthritis

More information

Optimising Safe & Appropriate Medicines Use and Deprescribing. Katie Smith, Director, East Anglia Medicines Information Service February 2014

Optimising Safe & Appropriate Medicines Use and Deprescribing. Katie Smith, Director, East Anglia Medicines Information Service February 2014 Optimising Safe & Appropriate Medicines Use and Deprescribing Katie Smith, Director, East Anglia Medicines Information Service February 2014 Background Objectives How & why the OSAMU document was developed

More information

Rational prescribing in the older adult. Assoc Prof Craig Whitehead

Rational prescribing in the older adult. Assoc Prof Craig Whitehead Rational prescribing in the older adult Assoc Prof Craig Whitehead Introduction Physioloical ageing and frailty Medication risks in older adults Drug Burden Anticholinergic and sedative drug burden Cascade

More information

Presented by: Ontario s Geriatric Steering Committee

Presented by: Ontario s Geriatric Steering Committee Polypharmacy: A Medication Management Opportunity Chris Fan-Lun, BScPhm, ACPR, CGP Clinical Practice Leader, Dept. of Pharmacy Services Mount Sinai Hospital, Sinai Health system Learning Objectives Provide

More information

COMMON DRUG RELATED PROBLEMS SEEN IN PACE AND MECHANISMS TO MITIGATE RISK

COMMON DRUG RELATED PROBLEMS SEEN IN PACE AND MECHANISMS TO MITIGATE RISK COMMON DRUG RELATED PROBLEMS SEEN IN PACE AND MECHANISMS TO MITIGATE RISK Robert L Alesiani, PharmD, CGP Chief Pharmacotherapy Officer CareKinesis, Inc. (a Tabula Rasa Healthcare Company) 2 3 4 5 Pharmacogenomics

More information

Polypharmacy: Guidance for Prescribing in Frail Adults

Polypharmacy: Guidance for Prescribing in Frail Adults Polypharmacy: Guidance for Prescribing in Frail Adults Why is reviewing polypharmacy important? Medication is by far the most common form of medical intervention. Four out of five people aged over 75 years

More information

DEPRESCRIBING IN THE ELDERLY

DEPRESCRIBING IN THE ELDERLY DEPRESCRIBING IN THE ELDERLY G E R I A T R I C S R E F R E S H E R D A Y W E D N E S D A Y, A P R I L 5 TH, 2 0 1 7 V É R O N I Q U E F R E N C H M E R K L E Y, M D, C C F P ( C O E ) B R U Y È R E C O

More information

POLYPHARMACY IN OLDER ADULTS AND BEERS CRITERIA UPDATE

POLYPHARMACY IN OLDER ADULTS AND BEERS CRITERIA UPDATE POLYPHARMACY IN OLDER ADULTS AND BEERS CRITERIA UPDATE Jeannie Kim Lee, PharmD, BCPS, CGP Clinical Pharmacy Director College of Pharmacy The University of Arizona Learning Objectives: State the risks of

More information

Pitfalls in Pharmacotherapy of Geriatrics

Pitfalls in Pharmacotherapy of Geriatrics Pitfalls in Pharmacotherapy of Geriatrics DR Ali M. Alyami (M Pharm., PhD) Case Study An 85 year old female with a history of atrial fibrillation, stroke, dementia, and hypertension, who is receiving chronic

More information

Polypharmacy and the Older Adult. Leslie Baker, PharmD, BCGP Umanga Sharma, MD

Polypharmacy and the Older Adult. Leslie Baker, PharmD, BCGP Umanga Sharma, MD Polypharmacy and the Older Adult Leslie Baker, PharmD, BCGP Umanga Sharma, MD Objectives Identify what polypharmacy is Identify factors leading to polypharmacy Discuss consequences of polypharmacy Identify

More information

Iatrogenesis in the frail elderly

Iatrogenesis in the frail elderly Iatrogenesis in the frail elderly Professor Michael Dooley Director of Pharmacy Alfred Health Professor of Clinical Pharmacy Centre for Medicine Use and Safety Monash University Iatrogenesis in the frail

More information

Tackling inappropriate polypharmacy in NHS Scotland

Tackling inappropriate polypharmacy in NHS Scotland Tackling inappropriate polypharmacy in NHS Scotland Francesca Aaen Lead Care Homes Pharmacist - NHS Lanarkshire Heather Harrison - Senior Prescribing Advisor/ Chronic Pain Primary Care Service Development

More information

PRESCRIBING IN THE ELDERLY. CARE HOME PHARMACY TEAM Bhavini Shah, Eleesha Pentiah & Puja Vyas

PRESCRIBING IN THE ELDERLY. CARE HOME PHARMACY TEAM Bhavini Shah, Eleesha Pentiah & Puja Vyas PRESCRIBING IN THE ELDERLY CARE HOME PHARMACY TEAM Bhavini Shah, Eleesha Pentiah & Puja Vyas LEARNING OUTCOMES Medicines Optimisation The effects of aging on health and medicines. Polypharmacy Acute Kidney

More information

STOPP START Toolkit Supporting Medication Review in the Older Person

STOPP START Toolkit Supporting Medication Review in the Older Person STOPP START Toolkit Supporting Medication Review in the Older Person STOPP: Screening Tool of Older People s potentially inappropriate Prescriptions START: Screening Tool to Alert doctors to Right (appropriate,

More information

Taking the harm out of Polypharmacy Step by step. Karen Reid and Claire Stein Lead Integrated Care Pharmacist NHS Lothian

Taking the harm out of Polypharmacy Step by step. Karen Reid and Claire Stein Lead Integrated Care Pharmacist NHS Lothian Taking the harm out of Polypharmacy Step by step Karen Reid and Claire Stein Lead Integrated Care Pharmacist NHS Lothian Presentation: Polypharmacy Overview of the 2015 guidelines The Seven Steps Application

More information

If a bad thing is happening to a patient, a drug did it until proven otherwise

If a bad thing is happening to a patient, a drug did it until proven otherwise Dr Vicki s First Rule of Geriatrics Deprescribing in the Elderly Victoria Braund MD, FACP, CMD Director, Division of Geriatrics NorthShore University HealthSystem Medical Director, Brandel Health & Rehab

More information

Polypharmacy. A CPPE distance learning programme

Polypharmacy. A CPPE distance learning programme A CPPE distance learning programme DLP 177 January 2016 Contents About CPPE distance learning programmes About this learning programme Glossary of key terms v vii ix Contents Section 1 The problem with

More information

Selecting the right patient for medication reviews

Selecting the right patient for medication reviews Selecting the right patient for medication reviews Prof dr Petra Denig, Clinical Pharmacy & Pharmacology, University Medical Center Groningen, the Netherlands 2 Who is in need of medication review: can

More information

From MCI to Dementia DR YU- MIN LIN GERIATRICIAN AUG 2018

From MCI to Dementia DR YU- MIN LIN GERIATRICIAN AUG 2018 From MCI to Dementia DR YU- MIN LIN GERIATRICIAN AUG 2018 Overview What is dementia? Common causes Normal cognitive decline Abnormal decline and mild cognitive impairment How do we manage dementia Can

More information

Geriatric Pharmacology

Geriatric Pharmacology Geriatric Pharmacology Janice Scheufler R.Ph.,PharmD, FASCP Clinical Pharmacist Hospice of the Western Reserve Objectives List three risk factors for adverse drug events in the elderly Discuss two physiological

More information

Supplemental materials for:

Supplemental materials for: Supplemental materials for: Wallis KA, Andrews A, Henderson M. Swimming against the tide: primary care physicians views on deprescribing in everyday practice. Ann Fam Med. 2017;15(4):341-346. General Practice

More information

Deprescribing Unnecessary Medications: A Four-Part Process

Deprescribing Unnecessary Medications: A Four-Part Process Deprescribing Unnecessary Medications: A Four-Part Process Scott Endsley, MD Fam Pract Manag. 2018;25(3):28-32. Abstract and Introduction Introduction www.medscape.com Ms. Horatio is a 76-year-old patient

More information

Disclosures. Use caution in the elderly: review of safe and effective medication use in older patients. Institute of Medicine. Learning Objectives

Disclosures. Use caution in the elderly: review of safe and effective medication use in older patients. Institute of Medicine. Learning Objectives Use caution in the elderly: review of safe and effective medication use in older patients Disclosures I have no disclosures or conflicts of interest related to this presentation John T. Holmes, PharmD,

More information

Polypharmacy and Deprescribing for Older People

Polypharmacy and Deprescribing for Older People Polypharmacy and Deprescribing for Older People Sarah Hilmer Head of Department, Clinical Pharmacology and Senior Staff Specialist Aged Care, RNSH Conjoint Professor of Geriatric Pharmacology, Sydney University

More information

Deprescribing with Confidence Dr Sanjay Suman MD FRCP

Deprescribing with Confidence Dr Sanjay Suman MD FRCP Deprescribing with Confidence Dr Sanjay Suman MD FRCP Clinical Director Elderly Care and Stroke Medway NHS Foundation Trust Kent 45% of all medications prescribed for 65 years 1 1. Wynne et al Maturitas

More information

Safe Prescribing in Dementia

Safe Prescribing in Dementia Safe Prescribing in Dementia Dr Daniel Harwood Consultant Psychiatrist and Clinical Director, London Strategic Clinical Network Gurdeep Kaur Major Rapid Access Team Senior Pharmacist, Camden CNWL NHS Trust

More information

STOPP and START criteria October 2011

STOPP and START criteria October 2011 # START and STOPP are newer criteria to identify potentially inappropriate medications in elderly, including drug drug and drug disease interactions, drugs which increase risk of falls and drugs which

More information

START, STOPP, Beers Oh My! Navigating the World of Geriatric Pharmacy

START, STOPP, Beers Oh My! Navigating the World of Geriatric Pharmacy START, STOPP, Beers Oh My! Navigating the World of Geriatric Pharmacy Jessica DiLeo, PharmD Kate Murphy, PharmD OBJECTIVES Identify pharmacodynamic and pharmacokinetic parameters that may influence treatment

More information

Polypharmacy and Anticholinergic Burden in Hospitalised Older Patients - A Cross Sectional Audit

Polypharmacy and Anticholinergic Burden in Hospitalised Older Patients - A Cross Sectional Audit INTERNATIONAL JOURNAL of BIOMEDICAL SCIENCE ORIGINAL ARTICLE Polypharmacy and Anticholinergic Burden in Hospitalised Older Patients - A Cross Sectional Audit Joanna Ulley 1, Sakila Sickander 2, Ahmed H.

More information

Screening tools for elderly patients in primary care

Screening tools for elderly patients in primary care Screening tools for elderly patients in primary care Cristín Ryan 1 Prof. Julia Kennedy 1 Dr. Denis O Mahony 2 Dr. Stephen Byrne 1 Co-Investigator: Dr. Paul Gallagher 2 1 Pharmaceutical Care Research Group,

More information

Medication Use in Older Adults

Medication Use in Older Adults Medication Use in Older Adults F. Michael Gloth, III, MD, AGSF, FACP, CMD Clinical Professor Department of Geriatrics, Florida State University College of Medicine Associate Professor of Medicine Division

More information

Frailty: what s it all about?

Frailty: what s it all about? Frailty: what s it all about? What is frailty? 1. an inevitable consequence of aging 2. A state due to multiple long term conditions 3. A condition in which the person becomes fragile 4. A state associated

More information

Medicines optimisation for older people with disabilities

Medicines optimisation for older people with disabilities Medicines optimisation for older people with disabilities Riddhika Joshi Care of older people and stroke pharmacist Objectives Medicines Optimisation Examples Identifying patients PREVENT Targeting patients

More information

Disclosure. The elderly at risk: reducing medications safely to meet life s changes. Relevant financial relationships.

Disclosure. The elderly at risk: reducing medications safely to meet life s changes. Relevant financial relationships. The elderly at risk: reducing medications safely to meet life s changes Barbara Farrell BScPhm, PharmD, FCSHP European Society of Hospital Pharmacists Conference March 2017 Disclosure Relevant financial

More information

Shared decision making for stepdown and stopping decisions. Michael R. Gionfriddo Pharm.D, Ph.D Geisinger Center for Pharmacy Innovation and Outcomes

Shared decision making for stepdown and stopping decisions. Michael R. Gionfriddo Pharm.D, Ph.D Geisinger Center for Pharmacy Innovation and Outcomes Shared decision making for stepdown and stopping decisions Michael R. Gionfriddo Pharm.D, Ph.D Geisinger Center for Pharmacy Innovation and Outcomes 1 Disclosures I have had travel and lodging paid for

More information

Use caution in the elderly: review of safe and effective medication use in older patients

Use caution in the elderly: review of safe and effective medication use in older patients Use caution in the elderly: review of safe and effective medication use in older patients John T. Holmes, PharmD, BCPS Assistant Professor of Family Medicine and Pharmacy Practice In support of improving

More information

Akinbolade O, Husband A, Forrest S, Todd A. Deprescribing in advanced illness. Progress in Palliative Care 2016, 24(5),

Akinbolade O, Husband A, Forrest S, Todd A. Deprescribing in advanced illness. Progress in Palliative Care 2016, 24(5), Akinbolade O, Husband A, Forrest S, Todd A. Deprescribing in advanced illness. Progress in Palliative Care 2016, 24(5), 268-271 Copyright: This is an Accepted Manuscript of an article published by Taylor

More information

Optimizing medication in caring for seniors living with frailty: Five perspectives

Optimizing medication in caring for seniors living with frailty: Five perspectives Optimizing medication in caring for seniors living with frailty: Five perspectives Community Care Shanna Trenaman BScH, BScPharm, MAHSR, ACPR, PhD(student) Project Manager for A Collaborative Intervention

More information

Polypharmacy & De-prescribing In Older Adults

Polypharmacy & De-prescribing In Older Adults Polypharmacy & De-prescribing In Older Adults Maryland Association of Osteopathic Physicians Annual Meeting September 15, 2018 Elizabeth Phung, DO Lead Clinical Associate Physician Beacham Center for Geriatric

More information

New approaches to Polypharmacy: Oligopharmacy and Deprescribing

New approaches to Polypharmacy: Oligopharmacy and Deprescribing East & outh East England pecialist harmacy ervices East of England, London, outh Central & outh East Coast Medicines Use and afety New approaches to olypharmacy: Oligopharmacy and Deprescribing Nina Barnett,

More information

Objectives. Polypharmacy Seminar. Causes of Polypharmacy. Polypharmacy 8/05/12. National Prescribing Curriculum Module

Objectives. Polypharmacy Seminar. Causes of Polypharmacy. Polypharmacy 8/05/12. National Prescribing Curriculum Module Polypharmacy Seminar Objectives On completion of this module you should be able to: state the major guiding principles in rational prescribing recognise, and substantiate, over-prescribing or inappropriate

More information

Polypharmacy. Polypharmacy. Suboptimal Prescribing in Older Adults. Kenneth Schmader, MD Professor of Medicine-Geriatrics

Polypharmacy. Polypharmacy. Suboptimal Prescribing in Older Adults. Kenneth Schmader, MD Professor of Medicine-Geriatrics Polypharmacy Kenneth Schmader, MD Professor of Medicine-Geriatrics Polypharmacy Definition Causes Consequences Prevention/management Suboptimal Prescribing in Older Adults Overuse Polypharmacy Underuse

More information

Pharmacology in the Elderly

Pharmacology in the Elderly Pharmacology in the Elderly James Hardy Geriatrician, Royal North Shore Hospital A recent consultation Aspirin Clopidogrel Warfarin Coloxyl with senna Clearlax Methotrexate Paracetamol Pantoprazole Cholecalciferol

More information

PARKINS ON CENTER. Parkinson s Disease: Diagnosis and Management. Learning Objectives: Recognition of PD OHSU. Disclosure Information

PARKINS ON CENTER. Parkinson s Disease: Diagnosis and Management. Learning Objectives: Recognition of PD OHSU. Disclosure Information OHSU PARKINS ON CENTER Parkinson s Disease: Diagnosis and Management for Every MD Disclosure Information Grants/Research Support: National Parkinson Foundation, NIH, Michael J. Fox Foundation Consultant:

More information

MEDICINES USE AND SAFETY WEBINAR

MEDICINES USE AND SAFETY WEBINAR MEDICINES USE AND SAFETY WEBINAR Welcome to the Medicines Use and Safety Team Webinar: Medicines and Frailty with Lelly Oboh The webinar itself will start at 1pm in the meantime Carina Livingstone is doing

More information

Prescribing Drugs to the Elderly

Prescribing Drugs to the Elderly Answers to your questions from University of Toronto experts Prescribing Drugs to the Elderly Can drugs do more harm than good? M.A. is a 90-year-old man living at home. He has dementia and due to wandering

More information

Outcome Statement: National Stakeholders Meeting on Quality Use of Medicines to Optimise Ageing in Older Australians

Outcome Statement: National Stakeholders Meeting on Quality Use of Medicines to Optimise Ageing in Older Australians Outcome Statement: National Stakeholders Meeting on Quality Use of Medicines to Optimise Ageing in Older Australians Executive summary Australia has a significant opportunity to improve the quality use

More information

Deprescribing criteria based on NHS PrescQIPP/UKMI document Optimising Safe and Appropriate Medicines Use (OSAMU) [1]

Deprescribing criteria based on NHS PrescQIPP/UKMI document Optimising Safe and Appropriate Medicines Use (OSAMU) [1] Supplementary material for the paper The potential for deprescribing in care home residents with type 2 diabetes, by authors Lillan Mo Andreassen, Reidun Lisbet Skeide Kjome, Una Ørvim Sølvik, Julie Houghton,

More information

Maximizing Medication Safety UNIVERSITY OF HAWAII AUGUST 31, 2016

Maximizing Medication Safety UNIVERSITY OF HAWAII AUGUST 31, 2016 Maximizing Medication Safety UNIVERSITY OF HAWAII AUGUST 31, 2016 Adverse Drug Events (ADE s) RISK FACTORS FOR Adverse Drug Events (ADEs) 6 or more concurrent chronic conditions 12 or more doses of drugs/day

More information

Index. Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article titles are in boldface type. Note: Page numbers of article titles are in boldface type. A Adverse drug events, polypharmacy and perioperative considerations in elderly patients, 377 389 Age, and risk of postoperative urinary retention,

More information

Cover images courtesy of jk1991 at FreeDigitalPhotos.net Infographics courtesy of SIMPATHY consortium

Cover images courtesy of jk1991 at FreeDigitalPhotos.net Infographics courtesy of SIMPATHY consortium If using any content from this document, please acknowledge the Scottish Government Polypharmacy Model of Care Group, 2018. When referencing this document, please use the following format: Scottish Government

More information

Our Commitment to Quality and Patient Safety Core Measures

Our Commitment to Quality and Patient Safety Core Measures Calvert Memorial Hospital is committed to our community, with a focus on patient-centered care. High quality and safe patient care is not our goal, it is our priority. That means delivering the best possible

More information

Adjusting and Withdrawing Medications in the Elderly

Adjusting and Withdrawing Medications in the Elderly Adjusting and Withdrawing Medications in the Elderly Louise Mallet, B.Sc.Pharm., Pharm.D., CGP Professor in Clinical Pharmacy, Faculty of Pharmacy, University of Montreal Clinical Pharmacist in Geriatrics,

More information

There s A Pill For That (But should my patient be on it?) A Review of Tools for the Evaluation of Optimal Prescribing in Geriatric Patients

There s A Pill For That (But should my patient be on it?) A Review of Tools for the Evaluation of Optimal Prescribing in Geriatric Patients There s A Pill For That (But should my patient be on it?) A Review of Tools for the Evaluation of Optimal Prescribing in Geriatric Patients Marilyn N. Bulloch, PharmD, BCPS Assistant Clinical Professor

More information

Rationalizing Medications. Tan Jianming Senior Pharmacist KTPH

Rationalizing Medications. Tan Jianming Senior Pharmacist KTPH Rationalizing Medications Tan Jianming Senior Pharmacist KTPH + Older patients are more likely to: 2 Have multiple co-morbid diseases Have age-related physiological changes that result in a reduced tolerance

More information

Choosing Wisely Long Term Care Uniquely Canadian

Choosing Wisely Long Term Care Uniquely Canadian Choosing Wisely Long Term Care Uniquely Canadian Family Medicine Forum, Montreal November 11, 2017 Session ID S460 Room 512 ABEF Conflict of interest Dr. Fred Mather Waterloo Ontario Amgen Dr. Serge Gingras

More information

Geri-PARDY! (2015 Beers Criteria) Pharmacology Edition

Geri-PARDY! (2015 Beers Criteria) Pharmacology Edition Geri-PARDY! Pharmacology Edition (2015 Beers Criteria) Aurelio Muyot, MD, AGSF, FACP Assistant Professor College of Osteopathic Medicine Touro University Nevada Objectives Review the 2015 Beers Criteria

More information

Medication Reviews within Care Homes. Catherine Armstrong

Medication Reviews within Care Homes. Catherine Armstrong Medication Reviews within Care Homes Catherine Armstrong What is a Medication Review? A structured, critical examination of a patient s medicines with the objective of reaching an agreement with the patient

More information

The Role of Pharmacists achieving international best practice standards and realising key opportunities.

The Role of Pharmacists achieving international best practice standards and realising key opportunities. The Role of Pharmacists achieving international best practice standards and realising key opportunities. Dr. Stephen Byrne Senior Lecturer in Clinical Pharmacy & Director of the MSc in Clinical Pharmacy

More information

Managing medicines in older people. Jane Noble and Caroline Ralph

Managing medicines in older people. Jane Noble and Caroline Ralph Managing medicines in older people Jane Noble and Caroline Ralph Where? Community Hospital Care Home What? Prescribing Dispensing Administering Case 1 84 year old lady Admitted with reduced mobility Recurrent

More information

Management of DM in Older Adults: It s not all about sugar! Who needs treatment for DM? Peggy Odegard, Pharm.D., BCPS, CDE

Management of DM in Older Adults: It s not all about sugar! Who needs treatment for DM? Peggy Odegard, Pharm.D., BCPS, CDE Management of DM in Older Adults: It s not all about sugar! Peggy Odegard, Pharm.D., BCPS, CDE Who needs treatment for DM? 87 year old, frail male with moderately severe dementia living in NH with persistent

More information

Deprescribing in CKD patients: Is less more? Speaker: Dr. Judith G. Marin, PharmD

Deprescribing in CKD patients: Is less more? Speaker: Dr. Judith G. Marin, PharmD 2016 Deprescribing in CKD patients: Is less more? Speaker: Dr. Judith G. Marin, PharmD Case Mr. Kid Ney is a 75 y/o patient who has been on dialysis for the last 4 years (PD, then HD). PMHx: HTN, DM,

More information

9/6/2017 DEPRESCRIBING SAFELY IN THE OLDER ADULT. What is Deprescribing??? What leads to overmedication?

9/6/2017 DEPRESCRIBING SAFELY IN THE OLDER ADULT. What is Deprescribing??? What leads to overmedication? DEPRESCRIBING SAFELY IN THE OLDER ADULT Pennsylvania Coalition of Nurse Practitioners State Conference November 4, 2017 Cynthia Blevins, DNP CRNP General Internal Medicine of Lancaster What is Deprescribing???

More information

The role of medication in falls risk

The role of medication in falls risk The role of medication in falls risk Patrick A. Ball, Foundation Professor of Rural Pharmacy, Charles Sturt University, Wagga Wagga Lecture outline The aged are not created equal Insidious nature of onset

More information

2/11/2016. Managing Polypharmacy: Evidence-based Dissection of Pharmaceuticals. Disclosure. Objectives

2/11/2016. Managing Polypharmacy: Evidence-based Dissection of Pharmaceuticals. Disclosure. Objectives Managing Polypharmacy: Evidence-based Dissection of Pharmaceuticals Heather Veeder MD Medical Director VITAS Healthcare San Antonio, TX Adjunct Professor of Medicine University of Texas Health Science

More information

From medicines reconciliation to medicines review. Dr. Fatma Karapinar Hospital pharmacistepidemiologist

From medicines reconciliation to medicines review. Dr. Fatma Karapinar Hospital pharmacistepidemiologist From medicines reconciliation to medicines review Dr. Fatma Karapinar Hospital pharmacistepidemiologist Conflict of interest Nothing to disclose Questions Medication review is more important than medicines

More information

Identifying Inappropriate Medications and Deprescribing Strategies ANGELA M. HILL, PHARM.D., RCPH GWEP JUNE 9, 2017

Identifying Inappropriate Medications and Deprescribing Strategies ANGELA M. HILL, PHARM.D., RCPH GWEP JUNE 9, 2017 Identifying Inappropriate Medications and Deprescribing Strategies ANGELA M. HILL, PHARM.D., RCPH GWEP LEARN@LUNCH JUNE 9, 2017 Objectives of Talk Identify inappropriate medications in a medication regimen

More information

BLCS 1-Clinical Overview. Dr. Chris Rauscher Clinical Lead Shared Care Polypharmacy Risk Reduction Initiative

BLCS 1-Clinical Overview. Dr. Chris Rauscher Clinical Lead Shared Care Polypharmacy Risk Reduction Initiative BLCS 1-Clinical Overview Dr. Chris Rauscher Clinical Lead Shared Care Polypharmacy Risk Reduction Initiative Fraser Health Guide To Person-Centered Medication Decisions Factors to Consider When Systematically

More information

Frailty & Polypharmacy

Frailty & Polypharmacy Frailty & Polypharmacy Elderly with LUTS Recognition and Management Dr Sanjay Suman MD FRCP Clinical Director Elderly Care Medway Maritime Hospital Kent Declaration of interests Honoraria and Advisory

More information

50 years of pharmacovigilance: unfinished job

50 years of pharmacovigilance: unfinished job 50 years of pharmacovigilance: unfinished job Joan-Ramon Laporte The role of pharmacoepidemiology in medicines regulation 108 market withdrawals in F, D & UK, 1961-93 Fulminant hepatitis Liver toxicity

More information

Polypharmacy in the Elderly

Polypharmacy in the Elderly Polypharmacy in the Elderly Or How Scotland invented the Modern World Sir William Ferguson Anderson 1914-2001 Became the first Professor of Geriatrics in the world when he was appointed to the David Cargill

More information

ASPIRIN MISUSE AT HOME ACCORDING TO START AND STOPP IN FRAIL OLDER PERSONS

ASPIRIN MISUSE AT HOME ACCORDING TO START AND STOPP IN FRAIL OLDER PERSONS ASPIRIN MISUSE AT HOME ACCORDING TO START AND STOPP IN FRAIL OLDER PERSONS O. Dalleur 1,4, B. Boland 2,3, A. Spinewine 4-5 1 Pharmacy and 2 Geriatric Medicine, St-Luc university Hospital, 3 Institute of

More information

Targeted Deprescribing in Patients on Hemodialysis to Decrease Polypharmacy

Targeted Deprescribing in Patients on Hemodialysis to Decrease Polypharmacy Targeted Deprescribing in Patients on Hemodialysis to Decrease Polypharmacy Presentation Objectives Discuss Polypharmacy In HD patients Define Deprescribing Review results of the pilot study on deprescribing

More information

Objectives. Antipsychotics 7/25/2016. LeadingAge Florida 53rd Annual Convention & Exposition

Objectives. Antipsychotics 7/25/2016. LeadingAge Florida 53rd Annual Convention & Exposition Reducing the Use of Antipsychotics in Long Term Care Communities Alan W. Obringer RPh, CPh, CGP Executive Director Senior Care Pharmacy Objectives Recognize the clinical evidence for the need to change

More information

Primary Care Approach for Evaluating the Risk of Falls with Elderly Patients. Danielle Hansen, DO, MS (Med Ed), MHSA

Primary Care Approach for Evaluating the Risk of Falls with Elderly Patients. Danielle Hansen, DO, MS (Med Ed), MHSA Primary Care Approach for Evaluating the Risk of Falls with Elderly Patients Danielle Hansen, DO, MS (Med Ed), MHSA Clinical Assistant Professor, LECOM Associate Director, LECOM Institute for Successful

More information

Appendix L: Research recommendations

Appendix L: Research recommendations 1 L.1 Dementia diagnosis (amyloid PET imaging) recommendation 1 Index Test Reference Test(s) Does amyloid PET imaging provide additional diagnostic value, and is it cost effective, for the diagnosis of

More information

Diabetes and the Elderly: Medication Considerations When Determining Benefits and Risks

Diabetes and the Elderly: Medication Considerations When Determining Benefits and Risks Diabetes and the Elderly: Medication Considerations When Determining Benefits and Risks Gretchen M. Ray, PharmD, PhC, BCACP, CDE Associate Professor UNM College of Pharmacy September 7 th, 2018 DISCLOSURES

More information

Evidence-Based Clinical Practice Guideline for Deprescribing Cholinesterase Inhibitors and Memantine in People with Dementia

Evidence-Based Clinical Practice Guideline for Deprescribing Cholinesterase Inhibitors and Memantine in People with Dementia Evidence-Based Clinical Practice Guideline for Deprescribing Cholinesterase Inhibitors and Memantine in People with Dementia ADI 2018, Chicago FACULTY OF MEDICINE Dr Emily Reeve NHMRC Cognitive Decline

More information

Falls Assessment and Medication

Falls Assessment and Medication Falls Assessment and Medication Professor T.Masud President-Elect British Geriatrics Society Nottingham University Hospitals NHS Trust, UK Visiting Professor University of Southern Denmark Mrs GH is a

More information

Public Dissemination Effective: January 2018

Public Dissemination Effective: January 2018 Board of Pharmacy Specialties Board Certified Geriatric Pharmacist (BCGP) Detailed Content Outline 1. GENERAL PRINCIPLES OF AGING (20%) A. Apply the knowledge of physiologic changes associated with aging

More information

Optimising prescribing in primary care in the face of multimorbidity and polypharmacy

Optimising prescribing in primary care in the face of multimorbidity and polypharmacy University of Dundee School of Medicine Optimising prescribing in primary care in the face of multimorbidity and polypharmacy Bruce Guthrie Professor of Primary Care Medicine, University of Dundee NICE

More information

Family Medicine for English language students of Medical University of Lodz. Seminar 12. Elderly care. Przemysław Kardas MD PhD

Family Medicine for English language students of Medical University of Lodz. Seminar 12. Elderly care. Przemysław Kardas MD PhD Family Medicine for English language students of Medical University of Lodz Seminar 12 Elderly care Przemysław Kardas MD PhD Europe is facing demographic challenge 2014 2080 2 3 Old vs young: major differences

More information

Case Study 6: Implementing and Evaluating the Leicester, Leicestershire and Ruthland Falls Pathway Cheryl Davenport and Niki Evans-Ward

Case Study 6: Implementing and Evaluating the Leicester, Leicestershire and Ruthland Falls Pathway Cheryl Davenport and Niki Evans-Ward Case Study 6: Implementing and Evaluating the Leicester, Leicestershire and Ruthland Falls Pathway Cheryl Davenport and Niki Evans-Ward Leicestershire County Council and Evolve Solutions IMPLEMENTING AND

More information

Toledo Hospital Clinical Quality Indicators. Effective - Heart Attack

Toledo Hospital Clinical Quality Indicators. Effective - Heart Attack Effective - Heart Attack This page shows information on effective measures for patients who had heart attacks. "Effective care" means patients are given treatments that scientific evidence has shown leads

More information

PRESCRIBING PRACTICE IN DELIRIUM. John Warburton Critical Care Pharmacist

PRESCRIBING PRACTICE IN DELIRIUM. John Warburton Critical Care Pharmacist PRESCRIBING PRACTICE IN DELIRIUM John Warburton Critical Care Pharmacist Learning outcomes Modifiable medication risk factors for delirium An appreciation of contributing factors modifiable with medicines

More information

Delirium. Geriatric Giants Lecture Series Divisions of Geriatric Medicine and Care of the Elderly University of Alberta

Delirium. Geriatric Giants Lecture Series Divisions of Geriatric Medicine and Care of the Elderly University of Alberta Delirium Geriatric Giants Lecture Series Divisions of Geriatric Medicine and Care of the Elderly University of Alberta Overview A. Delirium - the nature of the beast B. Significance of delirium C. An approach

More information

Polypharmacy: Guidance for Prescribing Figure 2: A Practical Guide to Stopping Medication in the Elderly

Polypharmacy: Guidance for Prescribing Figure 2: A Practical Guide to Stopping Medication in the Elderly Polypharmacy: Guidance for Prescribing Figure 2: A Practical Guide to Stopping Medication in the Elderly July 2014 This guidance has been prepared by Emyr Jones, Macmillan Palliative Care Pharmacist, Aneurin

More information

The PROMPT criteria: Development and validation of prescribing indicators in middle-aged adults

The PROMPT criteria: Development and validation of prescribing indicators in middle-aged adults The PROMPT criteria: Development and validation of prescribing indicators in middle-aged adults Dr. Janine Cooper, Professor Carmel Hughes, Dr. Cristín Ryan, Professor Susan Smith, Dr. Emma Wallace, Dr.

More information

Appendix 1: Service self-assessment

Appendix 1: Service self-assessment Appendix 1: Service self-assessment Frailty Screening Are we delivering high-quality care for frail older people? We are assessing for frailty in people aged 65+ at every entry into the service using a

More information

Condition/Procedure Measure Compliance Criteria Reference Attribution Method

Condition/Procedure Measure Compliance Criteria Reference Attribution Method Premium Specialty: Cardiology Credentialed Specialties include: Cardiac Diagnostic, Cardiology, Cardiovascular Disease, Clinical Cardiac Electrophysiology, and Interventional Cardiology This document is

More information

Briefing Document on Medication use and Falls

Briefing Document on Medication use and Falls Briefing Document on Medication use and Falls This document is intended as a briefing document and is not to be regarded as a document offering definitive legal advice in relation to the subject matter.

More information

Strategies to Decrease Medication Errors in Elderly. Abeer Zeitoun, Pharm. D Certified in Medication Safety, MCPHS

Strategies to Decrease Medication Errors in Elderly. Abeer Zeitoun, Pharm. D Certified in Medication Safety, MCPHS Strategies to Decrease Medication Errors in Elderly Abeer Zeitoun, Pharm. D Certified in Medication Safety, MCPHS Road Map..Outline 1. Introduction A. Definitions B. Geriatrics: High risk population C.

More information

IMPROVING MEDICATION AND OUTCOMES FOR OLDER FRAIL RESIDENTS OF LONG-TERM CARE FACILITIES

IMPROVING MEDICATION AND OUTCOMES FOR OLDER FRAIL RESIDENTS OF LONG-TERM CARE FACILITIES 1 IMPROVING MEDICATION AND OUTCOMES FOR OLDER FRAIL RESIDENTS OF LONG-TERM CARE FACILITIES SUSAN E. BRONSKILL, PHD On behalf of FRAILTY AND RECOGNIZING APPROPRIATE MEDICATION USE IN GERIATRICS AND LONG-TERM

More information

National Medicines Information Centre ST. JAMES S HOSPITAL DUBLIN 8 TEL or FAX

National Medicines Information Centre ST. JAMES S HOSPITAL DUBLIN 8 TEL or FAX National Medicines Information Centre ST. JAMES S HOSPITAL DUBLIN 8 TEL 01-4730589 or 1850-727-727 FAX 01-4730596 www.nmic.ie PRESCRIBING IN THE ELDERLY INTRODUCTION According to the most recent census

More information

Completed audit cycle to explore the use of the STOPP/START toolkit to optimise medication in psychiatric in-patients with dementia

Completed audit cycle to explore the use of the STOPP/START toolkit to optimise medication in psychiatric in-patients with dementia Completed audit cycle to explore the use of the STOPP/START toolkit to optimise medication in psychiatric in-patients with dementia Victor M. Aziz, Natalie Hill, Sugandha Kumar BJPsych Bulletin (08) 4,

More information

23/11/2018. Tools to stratify patients for clinical pharmacy interventions

23/11/2018. Tools to stratify patients for clinical pharmacy interventions Tools to stratify patients for clinical pharmacy interventions Professor Mike Scott Director of the Regional Medicines Optimisation Innovation Centre (MOIC) 47 th ESCP Symposium, Belfast 24 th October

More information

Polypharmacy, Medication Nihilism, and the art of de-prescribing

Polypharmacy, Medication Nihilism, and the art of de-prescribing Polypharmacy, Medication Nihilism, and the art of de-prescribing Temple Family Practice Review Course Leon S. Kraybill, MD, CMD Geriatrics, Lancaster General Hospital Physicians Division Chief, LGH Division

More information

Drug use in long term care. Graziano Onder Centro Medicina Invecchiamento Università Cattolica Sacro Cuore, Rome

Drug use in long term care. Graziano Onder Centro Medicina Invecchiamento Università Cattolica Sacro Cuore, Rome Drug use in long term care Graziano Onder Centro Medicina Invecchiamento Università Cattolica Sacro Cuore, Rome Polypharmacy in nursing home (USA) Concurrent use of 9 medications was reported for 39.7%

More information

Community Paramedic Training Program

Community Paramedic Training Program Date: March 2015 Page 1 of 5 Community Paramedic Training Program Training Program Components A. Classroom Training - The Community Paramedic (CP) training course (Appendix 1 Training Curriculum) was developed

More information